Manufacturer record
Sahika Pharmaceuticals Pvt. Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
1 batch manufactured by Sahika Pharmaceuticals Pvt. Ltd (Himachal Pradesh) was declared Not of Standard Quality in May 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: ST25417C, Pregabalin & Nortriptyline Tablets (exp Oct 2027). CDL, Kolkata (CDSCO lab) found it not of standard quality: The sample does not conform to Manufacturer's Specification with respect to Assay of Pregabalin. Listed in the May 2026 alert.
Records by type
1 record linked to Sahika Pharmaceuticals Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Pregabalin & Nortriptyline Tablets | Batch ST25417CMfg Nov 2025 · Exp Oct 2027 | The sample does not conform to Manufacturer's Specification with respect to Assay of PregabalinAssay | CDL, KolkataCDSCO lab | May 2026 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.